In sum, ACE2 deletion causes CD36/sirtuin 1 axis impairment and thereby contributes to the fat deposition in the liver leading to NAFLD, oxidative stress, and impaired insulin signaling (summarized in Figure 6). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.